相关实验视频

Updated: Jun 25, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

[甲状腺髓小癌的病理特征和预后分析]

D P Li¹, J M Zhang¹, Y H Zhang²

¹Department of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.

Zhonghua yi xue za zhi

|May 23, 2024

概括

甲状腺髓小癌 (MTMC) 呈现强烈的侵入性,大多数病例的预后良好. 然而,长期复发和死亡的重大风险仍然存在,尽管与较大的瘤的生存率相比较.

科学领域:

内分泌学在内分泌学.
在瘤学瘤学.
病理学病理学病理学

背景情况:

甲状腺髓性癌 (MTC) 是甲状腺C细胞的恶性瘤.
甲状腺髓小癌 (MTMC) 是MTC的最小形式,需要对其独特的临床行为和预后因素进行详细分析.

研究的目的:

调查甲状腺髓小癌 (MTMC) 的临床特征和预后.
为了比较MTMC的结果与较大的MTC瘤.

主要方法:

从2013年1月至2019年12月期间接受治疗的170名MTC患者的临床数据的回顾性分析.
专注于61名MTMC患者,根据瘤大小 (≤0.5厘米和>0.5-≤1.0厘米) 分为两组.
评估病理结果,生存率和复发模式.

主要成果:

在MTC案件中,MTMC占26.4%.
基于瘤大小 (≤0.5厘米与>0.5-≤1.0厘米) 的MTMC亚组之间没有观察到病理特征或预后的显著差异.
MTMC患者的无复发生存时间为83.1个月,其5年和10年生存率分别为93.4%和89.0%. 与较大的MTC相比,没有发现无复发生存的显著差异.

结论:

甲状腺髓小癌 (MTMC) 具有显著的侵入性.
虽然大多数MTMC患者的预后相对较好,但长期复发和死亡率的可能性仍然令人担忧.
对于MTMC的预后可与较大的MTC相提并论,这强调了需要进行警的随访.

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...